- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of The Pharma Industry in the 21st Century A
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of The Pharma Industry in the 21st Century A will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The The Pharma Industry in the 21st Century A VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The The Pharma Industry in the 21st Century A VRIO Analysis shows that the financial resources of The Pharma Industry in the 21st Century A are highly valuable as these help in investing into external opportunities that arise. These also help The Pharma Industry in the 21st Century A in combating external threats.
- According to the VRIO Analysis of The Pharma Industry in the 21st Century A, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The The Pharma Industry in the 21st Century A VRIO Analysis shows that The Pharma Industry in the 21st Century A's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of The Pharma Industry in the 21st Century A's products.
- According to the VRIO Analysis of The Pharma Industry in the 21st Century A, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for The Pharma Industry in the 21st Century A. These patents also provide The Pharma Industry in the 21st Century A with licensing revenue when it licenses these patents out to other manufacturers.
- The The Pharma Industry in the 21st Century A VRIO Analysis shows that The Pharma Industry in the 21st Century A’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for The Pharma Industry in the 21st Century A. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of The Pharma Industry in the 21st Century A, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The The Pharma Industry in the 21st Century A VRIO Analysis shows that the research and development at The Pharma Industry in the 21st Century A is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for The Pharma Industry in the 21st Century A. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of The Pharma Industry in the 21st Century A are found to be rare according to the VRIO Analysis of The Pharma Industry in the 21st Century A. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by The Pharma Industry in the 21st Century A VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as The Pharma Industry in the 21st Century A and inhibit competitive advantage. This means that the local food products result in competitive parity for The Pharma Industry in the 21st Century A. As this resource is valuable, The Pharma Industry in the 21st Century A can still make use of this resource.
- The employees of The Pharma Industry in the 21st Century A are a rare resource as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of The Pharma Industry in the 21st Century A are a rare resource as identified by the The Pharma Industry in the 21st Century A VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows The Pharma Industry in the 21st Century A to use them without interference from the competition.
- The distribution network of The Pharma Industry in the 21st Century A is a rare resource as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of The Pharma Industry in the 21st Century A. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of The Pharma Industry in the 21st Century A are costly to imitate as identified by the The Pharma Industry in the 21st Century A VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by The Pharma Industry in the 21st Century A provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of The Pharma Industry in the 21st Century A are also not costly to imitate as identified by the The Pharma Industry in the 21st Century A VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from The Pharma Industry in the 21st Century A by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of The Pharma Industry in the 21st Century A a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of The Pharma Industry in the 21st Century A are very difficult to imitate as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of The Pharma Industry in the 21st Century A is also very costly to imitate by competition as identified by the The Pharma Industry in the 21st Century A VRIO Analysis. This has been developed over the years gradually by The Pharma Industry in the 21st Century A. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of The Pharma Industry in the 21st Century A are organised to capture value as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for The Pharma Industry in the 21st Century A.
- The Patents of The Pharma Industry in the 21st Century A are not well organised as identified by the The Pharma Industry in the 21st Century A VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if The Pharma Industry in the 21st Century A starts selling patented products before the patents expire.
- The distribution network of The Pharma Industry in the 21st Century A is organised as identified by the VRIO Analysis of The Pharma Industry in the 21st Century A. The Pharma Industry in the 21st Century A uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for The Pharma Industry in the 21st Century A.
From the VRIO Analysis of The Pharma Industry in the 21st Century A, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of The Pharma Industry in the 21st Century A is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Yaz Thabit
5.0
The expert added the paper by composing the drafts. I am not disappointed here.
Grace Harrison
5.0
I'm entirely pleased with this service. If you want to save the time then appoint it. It won't let you down.
Mang Agoston
5.0
The revision was done by this company without additional cost and I’m satisfied with this company. Thanks a lot!
Matthew Blake
5.0
This is a very special site because it provided me the good quality fo the paper. Guys, you’re great! Thank you!
Next Articles
- Building A Worldwide Brain: Artificial Intelligence Inc Vrio Analysis
- Www.home_improvement.com (B) Vrio Analysis
- Quest International Vrio Analysis
- Note On Some Key Tax Issues For Multinational Business Vrio Analysis
- A New Business In The LEGO Group: LEGO Mindstorms Vrio Analysis
- Building LEGO Mindstorms Communities Vrio Analysis
- Www.home_improvement.com (A) Vrio Analysis
- Developing Managers For A Global Business At Johnson & Johnson Vrio Analysis
- Developing A Global Mindset At Johnson & Johnson 1998 Vrio Analysis
- Andersen Consulting's Global Brand Campaign Vrio Analysis
Previous Articles
- Stewart Instruments Ltd (Revised) Vrio Analysis
- ICI: Nobel's Explosives Company Vrio Analysis
- MJ Baskets Vrio Analysis
- Caesar's Writers Vrio Analysis
- Hindustan Lever Leaping A Millennium Vrio Analysis
- Nick Earle: 'The Plate Spinner' Vrio Analysis
- Under The Spotlight: It's 'Always Coca Cola' Vrio Analysis
- Unilever Indonesia: Linking Business Strategy To Job Creation Vrio Analysis
- Skandiabanken: Developing Information Capabilities For An Effective Customer Facing Strategy Vrio Analysis
- Papyrus Laser (C): Going Vistaprint.com Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!